Τετάρτη 23 Μαΐου 2018

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma, Published online: 24 May 2018; doi:10.1038/s41416-018-0104-z

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

https://ift.tt/2s7q9RI

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου